peripheral vascular disease, inclusion criteria: elective vascular surgery, age 30 to100years
Conditions
Interventions
Trade Name: Oxycontin
Product Name: Oxycodone
Pharmaceutical Form: Film-coated tablet
Pharmaceutical form of the placebo: Film-coated tablet
Route of administration of the placebo: Oral use
Trade Nam
Sponsors
Medical University of Vienna
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: see mentioned above Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: see mentioned above
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: comparison of quality in analgesic medication ( efficacy and adverse effects);Secondary Objective: differences regarding adverse effects;Primary end point(s): observation is finished on the third postoperative day; session planned four weeks after discharge to examine the developement of neuropathic pain | — |
Countries
Austria
Outcome results
None listed